These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 21614812)
1. [Effect of antiphospholipid antibodies on the formation and lysis of fibrin network in patients with recurrent miscarriage]. Marchi R; Maya I; Garmendia J Invest Clin; 2011 Mar; 52(1):35-47. PubMed ID: 21614812 [TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
3. Study of the fibrinolytic process in a patient with antiphospholipid syndrome. Marchi R; Garmendia J; Kanzler D; Fuenmayor J Blood Coagul Fibrinolysis; 2015 Apr; 26(3):239-45. PubMed ID: 24418942 [TBL] [Abstract][Full Text] [Related]
4. Haemostatic changes related to fibrin formation and fibrinolysis during the first trimester in normal pregnancy and in recurrent miscarriage. Marchi R; López Ramirez Y; Nagaswami C; Masova L; Pulido A; López Mora J; Muller A; Arocha-Piñango CL; Weisel JW Thromb Haemost; 2007 Apr; 97(4):552-7. PubMed ID: 17393017 [TBL] [Abstract][Full Text] [Related]
5. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women? Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284 [TBL] [Abstract][Full Text] [Related]
6. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name? Harris EN; Pierangeli SS Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301 [TBL] [Abstract][Full Text] [Related]
7. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W; Matthias T; Scharrer I Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [TBL] [Abstract][Full Text] [Related]
8. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation. Adams M Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304 [TBL] [Abstract][Full Text] [Related]
9. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin. Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome? Jaskowski TD; Wilson AR; Hill HR; Branch WD; Tebo AE Clin Chim Acta; 2009 Dec; 410(1-2):19-24. PubMed ID: 19751711 [TBL] [Abstract][Full Text] [Related]
11. Antiprothrombin antibody: why do we need more assays? Atsumi T; Koike T Lupus; 2010 Apr; 19(4):436-9. PubMed ID: 20353984 [TBL] [Abstract][Full Text] [Related]
12. Thrombophilic dimension of recurrent fetal loss in Indian patients. Vora S; Shetty S; Ghosh K Blood Coagul Fibrinolysis; 2008 Sep; 19(6):581-4. PubMed ID: 18685442 [TBL] [Abstract][Full Text] [Related]
13. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
14. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [TBL] [Abstract][Full Text] [Related]
16. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
17. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis. Yasuda S; Atsumi T; Ieko M; Koike T Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279 [TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Asherson RA; Cervera R; Merrill JT; Erkan D Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305 [TBL] [Abstract][Full Text] [Related]
19. [Antiphospholipid syndrome diagnosis: an update]. Visseaux B; Masliah-Planchon J; Fischer AM; Darnige L Ann Biol Clin (Paris); 2011; 69(4):411-8. PubMed ID: 21896405 [TBL] [Abstract][Full Text] [Related]
20. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation. Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]